PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells

Moolmuang B, Chaisaingmongkol J, Singhirunnusorn P, Ruchirawat M

Oncol Lett. 2024;23(1):316.

Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma

Kacar Z, Slud E, Levy D, Candia J, Budhu A, Forgues M, Wu X, Raziuddin A, Tran B, Shetty J, Pomyen Y, Chaisaingmongkol J, Rabibhadana S, Pupacdi B, Bhudhisawasdi V, Lertprasertsuke N, Auewarakul C, Sangrajrang S, Mahidol C, Ruchirawat M, Wang XW

Commun Biolog. 2024;7:383.

Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Do WL, Wang L, Forgues M, Liu J, Rabibhadana S, Pupacdi B, Zhao Y, Gholian H, Bhudhisawasdi V, Pairojkul C, Sukeepaisarnjaroen W, Pugkhem A, Luvira V, Lertprasertsuke N, Chotirosniramit A, Auewarakul CU, Ungtrakul T, Sricharunrat T, Sangrajrang S, Phornphutkul K, Budhu A, Harris CC, Mahidol C, Ruchirawat M, Wang XW

Cell Rep Med. 2023;4:101328.

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma

Pomyen Y, Chaisaingmongkol J, Rabibhadana S, Pupacdi B, Sriphan D, Chornkrathok C, Budhu A, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Auewarakul C, Ungtrakul T, Phornphutkul K, Sangrajrang S, Loffredo C, Harris C, Mahidol C, Wang X, Ruchirawat M*, the TIGER-LC Consortium

Sci Rep. 2023;13(1):11406.

Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma via m6A-mediated epitranscriptomic regulation

Hung MH, Chang CW, Wang KC, Chaisaingmongkol J, Ruchirawat M, Greten, T, Wang XW

Hepatology. 2023.
(In press)